HKSE - Delayed Quote HKD

Alphamab Oncology (9966.HK)

Compare
3.740 -0.100 (-2.60%)
At close: 4:08 PM GMT+8
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-202,839.000
-202,839.000
-300,308.000
-320,600.000
-347,180.000
--
Investing Cash Flow
-18,107.000
-18,107.000
850,756.000
574,264.000
-1,523,683.000
--
Financing Cash Flow
218,072.000
218,072.000
-310,902.000
363,902.000
186,579.000
--
Other Cash Adjustment Inside Change in Cash
--
--
--
--
--
399.000
End Cash Position
1,085,988.000
1,085,988.000
1,069,189.000
803,306.000
185,321.000
--
Capital Expenditure
-36,184.000
-36,184.000
-129,651.000
-158,119.000
-90,822.000
--
Issuance of Capital Stock
321,034.000
321,034.000
253.000
345.000
250,258.000
--
Issuance of Debt
465,000.000
465,000.000
401,074.000
692,466.000
110,350.000
--
Repayment of Debt
-540,000.000
-540,000.000
-679,890.000
-298,000.000
-131,000.000
--
Free Cash Flow
-239,023.000
-239,023.000
-429,959.000
-478,719.000
-438,002.000
--
12/31/2019 - 12/12/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers